Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.11.2023 | Case report

Ranibizumab

Membranoproliferative glomerulonephritis: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Gan G, et al. Membranoproliferative glomerulonephritis after intravitreal vascular growth factor inhibitor injections: A case report and review of the literature. [Review]. British Journal of Clinical Pharmacology 89 : 401-409, No. 1, Jan 2023. Available from: URL: http://doi.org/10.1111/bcp.15558 Gan G, et al. Membranoproliferative glomerulonephritis after intravitreal vascular growth factor inhibitor injections: A case report and review of the literature. [Review]. British Journal of Clinical Pharmacology 89 : 401-409, No. 1, Jan 2023. Available from: URL: http://​doi.​org/​10.​1111/​bcp.​15558
Metadaten
Titel
Ranibizumab
Membranoproliferative glomerulonephritis: case report
Publikationsdatum
01.11.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-49748-3

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Aflibercept

Case report

Linezolid

Case report

Elasomeran